FDA announces classwide label changes to extended-release/long-acting opioidsSeptember 10, 2013Addiction MedicineMental HealthPainRheumatologyDiabetesBusiness of Medicine
Perceived stigma linked to depression in female SLE patientsAugust 28, 2013Addiction MedicineMental HealthPainRheumatologyWomen's Health
FDA: Acetaminophen linked to rare, serious skin reactions, fatalitiesAugust 2, 2013DermatologyNeurologyPain
Smokin': Report finds marijuana has negligible effects on lungsJuly 30, 2013PainPulmonologyNeurologyMental Health
Pilot study: Vitamin D promising for diabetic painJuly 18, 2013EndocrinologyNeurologyDiabetesPainWomen's Health
Testosterone gel's pain relief modest in opioid-induced androgen deficiencyJuly 11, 2013Men's HealthEndocrinologyRheumatologyPain
FDA approves sublingual buprenorphine-naloxone combo for opioid dependence July 8, 2013Addiction MedicineMental HealthPain
